1. Home
  2. HALO vs INGR Comparison

HALO vs INGR Comparison

Compare HALO & INGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • INGR
  • Stock Information
  • Founded
  • HALO 1998
  • INGR 1906
  • Country
  • HALO United States
  • INGR United States
  • Employees
  • HALO N/A
  • INGR N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • INGR Packaged Foods
  • Sector
  • HALO Health Care
  • INGR Consumer Staples
  • Exchange
  • HALO Nasdaq
  • INGR Nasdaq
  • Market Cap
  • HALO 7.4B
  • INGR 8.4B
  • IPO Year
  • HALO N/A
  • INGR 1997
  • Fundamental
  • Price
  • HALO $54.54
  • INGR $136.75
  • Analyst Decision
  • HALO Buy
  • INGR Hold
  • Analyst Count
  • HALO 9
  • INGR 5
  • Target Price
  • HALO $63.56
  • INGR $150.20
  • AVG Volume (30 Days)
  • HALO 3.3M
  • INGR 467.7K
  • Earning Date
  • HALO 05-06-2025
  • INGR 05-06-2025
  • Dividend Yield
  • HALO N/A
  • INGR 2.34%
  • EPS Growth
  • HALO 55.40
  • INGR N/A
  • EPS
  • HALO 3.76
  • INGR 9.47
  • Revenue
  • HALO $1,084,306,000.00
  • INGR $7,361,000,000.00
  • Revenue This Year
  • HALO $25.77
  • INGR $3.18
  • Revenue Next Year
  • HALO $18.01
  • INGR $2.58
  • P/E Ratio
  • HALO $14.51
  • INGR $14.44
  • Revenue Growth
  • HALO 25.64
  • INGR N/A
  • 52 Week Low
  • HALO $42.01
  • INGR $111.54
  • 52 Week High
  • HALO $70.51
  • INGR $155.44
  • Technical
  • Relative Strength Index (RSI)
  • HALO 44.48
  • INGR 52.79
  • Support Level
  • HALO $52.43
  • INGR $135.00
  • Resistance Level
  • HALO $54.26
  • INGR $141.78
  • Average True Range (ATR)
  • HALO 3.42
  • INGR 2.77
  • MACD
  • HALO -0.49
  • INGR -0.06
  • Stochastic Oscillator
  • HALO 30.60
  • INGR 32.03

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About INGR Ingredion Incorporated

Ingredion is an ingredients provider for the food, beverage, brewing, and animal nutrition industries. The company processes corn, tapioca, potatoes, stevia, grains, fruits, gums, and vegetables into value-added ingredients. The company has two main product lines: specialty and core ingredients. Specialty ingredients includes starch-based texturizers, natural alternative sweeteners such as stevia, and plant proteins for alternative dairy and snacks. Core ingredients includes sweeteners, such as high-fructose corn syrup, and commodity starches, such as those used for sustainable packaging.

Share on Social Networks: